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EmerinThe nuclear lamina is thought to be a steric barrier to the herpesvirus capsid. Disruption of the lamina
accompanied by phosphorylation of lamina proteins is a conserved feature of herpesvirus infection. In HSV-1-
infected cells, protein kinase C (PKC) alpha and delta isoforms are recruited to the nuclear membrane and PKC
delta has been implicated in phosphorylation of emerin and lamin B. We tested two critical hypotheses about
the mechanism and signiﬁcance of lamina disruption. First, we show that chemical inhibition of all PKC
isoforms reduced viral growth ﬁve-fold and inhibited capsid egress from the nucleus. However, speciﬁc
inhibition of either conventional PKCs or PKC delta does not inhibit viral growth. Second, we show
hyperphosphorylation of emerin by viral and cellular kinases is required for its disassociation from the lamina.
These data support hypothesis that phosphorylation of lamina componentsmediates lamina disruption during
HSV nuclear egress., The University of Iowa, 3-432
+1 319 335 9006.
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All herpesviruses assemble newly formed capsids in the nucleus of
the host cell. To escape the nucleus, the capsids must traverse the
inner and outer nuclear membranes via an envelopment/de-envel-
opment process at the nuclear envelope (NE) to release un-enveloped
capsids into the cytoplasm {Mettenleiter, 2006 #251}.
The inner nuclear membrane (INM) is not, however, freely
accessible to large macromolecular complexes like a herpesvirus
capsid. The INM is supported by a complex meshwork of proteins
called the nuclear lamina (Aebi et al., 1986; Gruenbaum et al., 2005;
Worman and Courvalin, 2005). The lamina mesh is primarily
composed of intermediate ﬁlament-related proteins called lamins of
which there are three types: A, B, and C. The lamin A gene is
alternatively spliced to generate A and C types while the two B types
are encoded by separate genes (Gruenbaum et al., 2003). The lamin
meshwork is anchored to the INM via interactions with lamin
associated proteins (LAPs) (Worman and Courvalin, 2005). Many
LAPs such as emerin, the lamin B receptor (LBR), MAN1, and LAP2β
are inner nuclear membrane-bound proteins that bind both lamins
and chromatin (Holmer and Worman, 2001). The organization of the
nuclear periphery suggests that it may present multiple barriers to
herpesvirus envelopment. The presence of chromatin attached to the
lamina and the organization of the lamin proteins themselves may
each present a steric barrier. The spacing of structural elements of thelamin lattice (about 50 nm) is too small to allow passage of a
herpesvirus capsid, and physical measurements suggest that the
lamin network is quite stiff and resistant to deformation and therefore
unlikely to bend around a capsid during envelopment (Aebi et al.,
1986; Panorchan et al., 2004). It is likely that the lamina must be
disrupted in order for capsids to gain access to the INM.
Infection with wild-type herpesviruses results in changes in
nuclear architecture consistent with disruption of the nuclear lamina,
including: (i) enlargement of the nucleus demonstrated for HSV-1 and
HCMV (Bjerke and Roller, 2006a; Radsak et al., 1991; Simpson-Holley
et al., 2005); (ii) change in the shape of the nucleus from a smooth
ovoid to something that more closely resembles a raisin in contour,
demonstrated for HSV and HCMV (Bjerke and Roller, 2006a;
Hamirally et al., 2009; Radsak et al., 1991; Simpson-Holley et al.,
2004, 2005); (iii) changes in the localization of both A and B type
lamin proteins from a smooth, even lining of the INM to an uneven
distribution showing gross thickening of the lamin layer at some sites
and small perforations in the layer at other sites, demonstrated for
HSV-1, HSV-2, HCMV, MCMV, and EBV (Bjerke and Roller, 2006a;
Camozzi et al., 2008; Cano-Monreal et al., 2009; Hamirally et al., 2009;
Lee et al., 2008; Radsak et al., 1991; Reynolds et al., 2004; Simpson-
Holley et al., 2004, 2005); (iv) masking and unmasking of monoclonal
antibody epitopes on the lamin proteins that indicate a change in the
conformation or associations of the lamin proteins, seen with HSV-1
and HSV-2 (Reynolds et al., 2004; Cano-Monreal, 2009); (v)
redistribution of LAPs including LBR, LAP2β, and emerin in herpes
simplex infections (Bjerke and Roller, 2006b; Leach et al., 2007;
Morris et al., 2007; Scott and O'Hare, 2001; Simpson-Holley et al.,
2004).
Fig. 1. PKC activity required for HSV-1 replication. Replicate cultures of HEp-2 cells
were infected at an MOI of 5 with HSV-1(F) A) Cells were treated with DMSO or 10 μM
pan-PKC inhibitor bis-indolylmaleimide (BIM I) beginning at 5 h post infection (hpi).
Titer was determined at 24 hpi. Virus yields are expressed as plaque forming units
(PFU) per milliliter. Each data point represents the mean of ﬁve experiments. Error bars
indicate standard deviations. p-values were determined via a paired Student t-test.
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(Margalit et al., 2005) which is mediated by phosphorylation of lamins
and LAPsby cellular kinases including cyclin dependent kinase1 (Cdk1),
protein kinase C (PKC), mitogen-activated protein kinase (MAPK),
protein kinase A (PKA), casein kinase II, and AKT (Gruenbaum et al.,
2003, 2005; Margalit et al., 2005). Phosphorylation disrupts the lamina
protein–protein and protein–DNA interactions. A growing body of
evidence suggests that herpesviruses adapt this mechanism and induce
phosphorylation of nuclear lamina components to gain access to the
INM. HSV-1, HSV-2 and HCMV infections induce phosphorylation of all
three types of lamins (Cano-Monreal et al., 2009; Marschall et al., 2005;
Mou et al., 2007, 2008; Park and Baines, 2006). EBV and MCMV
infections induce phosphorylation of at least lamin A/C (Lee et al., 2008;
Muranyi et al., 2002). LAPs are also phosphorylated during herpesvirus
infection. Emerin is hyperphosphorylated and disconnected from the
lamina during HSV-1 and -2 infections however the mechanism and
signiﬁcance of this modiﬁcation remains untested (Leach et al., 2007;
Morris et al., 2007). It is unknown which emerin residues are modiﬁed
during HSV infection and if these modiﬁcations are required for its
disassociation from the NE.
Phosphorylation of lamina components during infection is mediated
by both viral and cellular kinases. Herpesviruses encode a conserved
protein kinase called CHPK (Conserved Herpesvirus Protein Kinase),
which shows similarities to Cdk1 in function and substrate speciﬁcity
(Hume et al., 2008; Kawaguchi and Kato, 2003). Cdk1, also known as
cdc2, has also been implicated in HSV-2 lamina disruption via its
putative role in emerin phosphorylation (Morris et al., 2007).
Involvement of the beta- and gamma-herpesvirus CHPKs in nuclear
laminadisruption andnuclear egresshas beenestablished (Krosky et al.,
2003; Lee et al., 2008), and the HCMV CHPK phosphorylates lamin
proteins on previously deﬁned CDK-dependent sites (Hamirally et al.,
2009).While there is no evidence that HSV-1 CHPK, pUL13, can directly
phosphorylate nuclear lamina proteins, the HSV-2 pUL13 can disrupt
lamin localization in transiently transfected cells and directly phos-
phorylate lamins in vitro (Cano-Monreal et al., 2009). Alpha-herpes-
viruses encode a second serine/threonine protein kinase designated
pUS3 in HSV. pUS3 mediates phosphorylation of lamina components,
including lamin A/C, and emerin, and regulates the degree of lamina
disruption (Bjerke and Roller, 2006b; Leach et al., 2007; Mou et al.,
2008).
During HSV-1, MCMV, and HCMV infections, PKC isoforms are
recruited to the NE by viral proteins that are required for lamina
disruption, suggesting that PKC activity may contribute to lamina-
disrupting phosphorylation events (Muranyi et al., 2002; Park and
Baines, 2006). There are ten PKC isoforms divided into three groups
that differ in their activation mechanisms and all isoforms may be
involved in herpesvirus-mediated lamina disruption. Conventional
PKC isoforms (cPKCs), such as protein kinase c alpha (PKC alpha),
require an efﬂux of calcium and diacylglycerol (DAG) for activation.
Novel PKC (nPKC) family members, such as PKC delta (encoded by the
PRKCD gene), are activated by DAG in a calcium-independentmanner.
Atypical PKCs (aPKC) such as PKC zeta do not require either for
activation (Reyland, 2009b).
Recruitment of PKCs to the NE appears to be isoform speciﬁc.
Although not all ten isoforms were tested, both PKC alpha and PKC
delta, but not PKC zeta, were recruited to the NE upon HSV-1 infection
(Park and Baines, 2006). Treatment of HSV infected cultures with
Rottlerin, a widely used putative PKC delta inhibitor, blocked lamin B
phosphorylation (Park and Baines, 2006). These data suggested a role
for PKC alpha and delta but not zeta in nuclear egress.
Recruitment of PKCs to the NE in herpesvirus infections requires
expression of the conserved proteins of the virus nuclear egress
complex. In HSV, these proteins are called pUL31 and pUL34, and they
form a complex that is required for events in lamina disruption
including redistribution of lamin proteins, masking and unmasking of
lamin epitopes during infection and full hyperphosphorylation andredistribution of emerin (Leach et al., 2007; Reynolds et al., 2004). In
HSV-1 infection, recruitment of both PKC alpha and PKC delta depends
on pUL34 expression (Park and Baines, 2006). In MCMV, M50/p38,
the pUL34 homolog, is required to recruit cPKCs to the NE (Muranyi et
al., 2002). HSV-1 induced emerin phosphorylation is dependent upon
both pUS3 kinase activity and pUL34 expression. The pUL34
dependent component of emerin hyperphosphorylation is sensitive
to inhibition by Rottlerin suggesting that PKC delta mediates emerin
hyperphosphorylation (Leach et al., 2007).
Despite the evidence for herpesvirus-dependent lamina disrup-
tion, it should be emphasized that the hypothesis that lamina
disruption is necessary for herpesvirus egress has not yet been
rigorously tested largely because all of the viral and cellular activities
that mediate lamina disruption may also have other functions in
infection and in nuclear egress. Experiments that speciﬁcally isolate
the effects of virus-induced lamina disruption on virus growth have
not been performed. Also, no study has yet directly demonstrated that
the observed phosphorylation of lamina components causes their
disconnection from other components of the lamina. The data
presented in this article support both of these hypotheses by showing
that (i) PKC family function is required both for efﬁcient replication of
HSV-1 and for nuclear egress, and (ii) emerin localization in the
infected cell is determined by phosphorylation state. Emerin
hyperphosphorylation is not sensitive to pan-PKC or DN-PKC delta
inhibition suggesting a role for a non-PKC isoform in emerin
phosphorylation. This non-PKC isoform or Rottlerin sensitive kinase
(RttSK) is sensitive to Rottlerin but not BIM I treatment.
Results
Inhibition of cellular kinases involved in lamina disruption inhibits viral
replication
To test the hypothesis that PKC activity is required for late events
of HSV-1 replication, speciﬁcally nuclear egress, activity of all PKC
isoforms was blocked with the pan-PKC small molecule inhibitor bis-
indolylmaleimide I (BIM I) (Toullec et al., 1991). HEp-2 cells were
infected with ﬁve plaque forming units (PFU)/cell of WT HSV-1(F),
treated with 10 μM BIM I or vehicle (DMSO) beginning at 5 h post
infection (hpi), and production of infectivity was measured at 24 hpi
(Fig. 1). This time of drug addition was chosen to allow at least the
entry and IE (immediate early) gene expression phases to occur un-
inhibited. 10 μM BIM I has been previously shown to inhibit all PKC
isoform activity (Toullec et al., 1991). BIM I treatment reduced the
infectivity compared to DMSO by nearly ﬁve-fold. Similar results were
obtained in Vero cells and at 16 hpi (not shown).
Toxicity, determined using the ATPLite system, was not observed
at the concentrations used for any of the inhibitors used in this study
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since BIM I treatment blocked PKC activation of the MAPK pathway
(Supplemental Figure 1) (Reyland, 2009a; Wang et al., 2003). Similar
results were obtained in Vero cells (data not shown). Collectively,
Fig. 1 and Supplemental Figure 1 suggest a signiﬁcant role for PKC
function in the late phase of HSV-1 replication.
PKC activity is required for extra-nuclear capsid accumulation
To determine if the decrease in viral infectivity produced by PKC
inhibition is due to a block to primary envelopment, Vero cells wereFig. 2. Inhibition of PKC blocks extra-nuclear capsid accumulation. Shown are digital
images of transmission electron micrographs (TEM) of Vero cells infected with ﬁve
PFU/cell HSV-1(F). Cells were treated with vehicle beginning at ﬁve hpi with vehicle
(A) or BIM I (B) ﬁxed with glutaraldehyde at 16 hpi, and thin sectioned for TEM. The
inset picture is approximately twice the magniﬁcation and shows an example of an
empty capsid (A and B capsids) (arrow) and a full capsid (C capsid) (arrow head).infected with ﬁve PFU/cell of WT HSV-1(F), treated with vehicle
(Fig. 2A) or 10 μM BIM I (Fig. 2B) beginning at ﬁve hpi, ﬁxed at 16 hpi,
and processed for TEM analysis. DMSO-treated, WT virus-infected
cells contained empty (A and B capsids (without DNA)) and full
capsids (C capsids (with DNA)) in four distinct sub-cellular compart-
ments: nucleus, perinuclear space\ER, cytoplasm (either as naked or
membrane-enclosed capsids), and cell surface (membrane-enclosed
capsids) (Fig. 2). Capsids were counted in the four distinct compart-
ments in 20 cells for each treatment condition and represented as a
percentage of total capsids (Table 1). In DMSO-treated cells, 33% of
virions were found in the nucleus. BIM I treatment increased the
number of nuclear virions to 77% of total. While 46% of virions in
DMSO-treated infected cells were found at the cell surface, only 9% of
BIM I-treated virions were at the cell surface. BIM I-treated cells either
had no or few capsids in the entire cell or the majority of the capsids
were located inside the nucleus (Table 1). The ratio of full to empty
capsids didnot dramatically changewithBIM I treatment (DMSO-7.90:1
vs. BIM I-7.92:1).
Many of the WT virus-infected, BIM I-treated cells, displayed
distinct characteristics of infection such as marginated chromatin
(Fig. 2B), and yet had few or no capsids in the cell. Furthermore, the
total number of capsids found in or on BIM I-treated cells was
decreased when compared to vehicle-treated cells (Table 1, total
DMSO-631 vs. BIM I-223). To determine if there was a statistical
difference in capsid accumulation, we compared the number of
capsids per cell in DMSO- and BIM I-treated cells using an unpaired
Student t-test (Table 1, mean DMSO-31.6 vs. BIM I-11.2) (http://
www.physics.csbsju.edu/stats/t-test.html). Inhibition of PKC with
BIM I changed the mean number of capsids per cell signiﬁcantly as
evaluated by the t-test (p=0.001). Collectively, these data suggest
BIM I inhibition of PKC inhibits (i) accumulation of capsids and (ii) the
ability of the capsids that are formed to egress from the nucleus.
PKC inhibition does not inhibit viral protein translation
The signiﬁcant reduction in the fraction of extra-nuclear capsids
produced in BIM I- treated, HSV-1(F)-infected cells compared to
vehicle control cells, indicated that BIM I inhibits nuclear egress
(Table 1). However, the reduction in the total number of capsids
observed in the presence of the pan-PKC inhibitor suggested its effect
on nuclear egress might result from inhibition of events preceding
capsid assembly, including expression of genes required for capsid
assembly and nuclear envelopment (Table 1).
To test the hypothesis that BIM I treatment inhibits late gene
expression necessary for efﬁcient capsid assembly and nuclear
egress, accumulation of viral proteins was tested in cells infected in
the presence of vehicle and BIM I. HEp-2 cells were infected with ﬁve
PFU/cell of HSV-1(F) and at ﬁve hpi, the cells began treatment with
DMSO (D) or BIM I (B). Total cell lysates were prepared at 16 hpi and
protein from equal numbers of cells was separated on an SDS-PAGE
gel and transferred to nitrocellulose (Fig. 3A). These samples were
subjected to western blot analysis for the following proteins: VP5
(leaky-late gene product and capsid protein), pUS11 and gC (archetypeTable 1
Assembly and egress intermediates in BIM I-treated cells.
Capsid number (% of total capsids)
Cellular compartment DMSO-treated BIM I-treated
Nucleus 221 (33%) 159 (71%)
Perinuclear space/ER 1 (0%) 7 (3%)
Cytoplasm 129 (20%) 38 (17%)
Cell surface 290 (46%) 19 (9%)
Total 631 (100%) 223 (100%)
Mean capsid/cell 31.6 11.2
Median capsid/cell 29.0±13.3a 1.5±11.1
a Average absolute deviation from median.
Fig. 3. PKC inhibitor inhibits cellular but not viral protein synthesis. (A) Digital images
of western blots of HEp-2 unlabeled total cell lysates prepared frommock-infected cells
or cells infected with ﬁve PFU/cell of HSV-1(F). At 16 hpi, total cell lysates were
prepared from equal numbers of cells. Cells were DMSO (D) or BIM I (B) treated
beginning at ﬁve hpi. Blots were probed with monoclonal antibodies to VP5, pUL34, gC,
and US11. (B) Autoradiogram of 35S-methionine labeled HEp-2 cell lysates from A.
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nuclear egress). BIM I treatment in infected cells had little to no effect on
the accumulation of VP5, gC, pUS11, or pUL34 compared to DMSO
treatment (compare lanes three to two). The same results were
achieved when equivalent amounts of total protein are loaded (data
not shown).
To test the hypothesis that BIM I treatment inhibits global late
gene expression, synthesis of late viral proteins was tested in cells
infected in the presence of vehicle or BIM I. HEp-2 cells were infected
with ﬁve PFU/cell of HSV-1(F) and beginning at ﬁve hpi, the cells
were treated with DMSO (D) or BIM I (B). Beginning at 14 hpi, cells
were labeled for 2 h with 35 S-methionine. Total cell lysates were
prepared at 16 hpi and protein from equal numbers of cells was
separated on an SDS-PAGE gel and visualized by autoradiography
(Fig. 3B). Upon infection with HSV-1(F), host protein synthesis was
turned off and viral protein synthesis was evident in DMSO-treated
samples (compare lanes two to four). When infected cells were
treated with BIM I little or no effect on total viral protein synthesis
was observed (compare lanes one to two). In individual experiments
we noted differences in the intensities of speciﬁc bands (e.g., at 80 K,
58 K, and 40 K in this experiment). These were not reproducible
between experiments. BIM I treatment reduced mock-infected HEp-2
protein synthesis (compare lanes three to four) as previously observed
(Soltoff, 2007; Wang et al., 2003). These data suggest that BIM I
mediated inhibition of nuclear egress is not due to inhibition of late gene
expression, and are consistent with the hypothesis that inhibition of
PKCs has speciﬁc inhibitory effects on both (i) accumulation of capsids
and (ii) egress of accumulated capsids from the nucleus.
Neither conventional PKCs nor PKC delta kinase activity are uniquely
required for HSV-1 replication
PKC alpha, a conventional (cPKC) isoform, is recruited to the NE
during HSV-1 infection and the entire class of cPKCs is recruited to therim duringMCMV infection suggesting a conserved and speciﬁc role for
cPKCs in herpesvirus nuclear egress (Muranyi et al., 2002; Park and
Baines, 2006). To test the hypothesis that cPKC isoforms are required for
optimal HSV-1 growth, cPKCs were inhibited with the small molecule
inhibitor Ro-31-7549 (Zhang et al., 1997). HEp-2 cells were infected
with ﬁve PFU/cell of WT HSV-1, treated with 1 μM Ro-31-7549 or
vehicle (DMSO) beginning at ﬁve hpi, and production of infectivity was
measured at 24 hpi (Fig. 4A). Treatment with Ro-31-7549 had no
signiﬁcant effect on replication compared to vehicle. Ro-31-7549
inhibits cPKC (PKC alpha) signaling, as previously reported, since it
partially blocked PKC signaling and activation of the MAPK pathway
(Supplemental Figure 2 A). Collectively, Fig. 4A and Supplemental
Figure 2 A do not suggest a unique, signiﬁcant role for cPKC function in
the late phase of HSV-1 replication.
HSV-1 also recruits PKC delta to the NE and treatment with
Rottlerin, a reported PKC delta inhibitor, reduces infection-induced
phosphorylation of lamin B and emerin (Leach et al., 2007; Park and
Baines, 2006). These data suggested that PKC delta contributed to
lamina disruption and might be required for nuclear egress. It has
become apparent with increasing research, however, that there are
many PKC delta-independent Rottlerin-dependent phenotypes (Lim
et al., 2009; Soltoff, 2007; Tillman et al., 2003; Wang et al., 2003),
necessitating the use of more speciﬁc methods to probe PKC delta
function. We used three approaches to reduce PKC delta activity to
test the hypothesis that PKC delta activity is speciﬁcally required for
viral replication.
First, we inhibited PKC delta activity by over-expression of
dominant-negative (DN) PKC delta (K376M) (Konishi et al., 1997).
Our strategywas to place a DN-PRKCD gene on the same plasmid as an
essential viral gene and then perform a complementation assay with
the virus lacking that essential gene. Two plasmids were created
expressing both FLAG-PKC delta (WT or DN) and the viral gene UL34.
These constructs are termed PRKCDwt-UL34 Duo or PRKCDdn-UL34
Duo. These plasmids allow for co-expression of both genes in the
transfected cell, however UL34 will only be expressed upon infection
with the UL34-null virus (vRR1072(tk+)) since the UL34 gene is
under the control of its viral promoter. If PKC delta activity is required
for HSV-1 replication, then the PRKCDdn-UL34 Duo plasmid should
inhibit complementation of the UL34-null virus. We tested for
efﬁcient gene expression from the Duo plasmids (Supplemental
Figure 2 B). We also conﬁrmed that DN-PKC delta (K376M-PRKCD)
expressed from the Duo system retains the dominant negative
function (Supplemental Figure 2 C).
To test the hypothesis that PKC delta activity is required for viral
growth, PKC delta activity was blocked with PRKCDdn-UL34 Duo in a
complementation assay. Vero cells were co-transfected for 24 h with
a transfection efﬁciency control plasmid, pCMVβ, and no UL34
(pRR1072), WT UL34 (pRR1072Rep), PRKCDwt-UL34 Duo, or
PRKCDdn-UL34 Duo. These Vero cells were infected with ﬁve PFU/
cell of UL34-null virus (vRR1072(tk+)) and at 18 hpi the amount of
infectivity produced was measured by plaque assay on the UL34
complementing cell line RepAC (Fig. 4B). The complementation
index for WT UL34 is set to 1.000 and the other conditions are
calculated relative to that. No pUL34 results in little virus production,
while pUL34 provided in trans supports replication as previously
shown. Co-expression of either WT- or DN-PKC delta appears to
slightly reduce complementation (Fig. 4B). However, there was no
signiﬁcant difference between WT- and DN-PKC delta suggesting
that DN-PKC delta did not have a speciﬁc inhibitory effect on
complementation. These data in Fig. 4 suggest that neither cPKCs nor
PKC delta kinase function is required for efﬁcient HSV replication.
Our second approach was to determine if reduction of PKC delta
protein levels would depress viral replication. HEp-2 clonal cell lines
constitutively expressing shRNA against human PKC delta were
generated (Supplemental Figure 3 A). There was not a signiﬁcant
difference between replication of HSV-1(F) in any of the shRNA-PKC
Fig. 4. cPKCs nor PKC delta are uniquely required for HSV-1 replication. (A) Cells were treated vehicle (DMSO) or 1 μM Ro-31-7549 beginning at ﬁve hpi. Titer was determined at
24 hpi. Virus yields are expressed as plaque forming units (PFU) per milliliter. Each data point represents the mean of six experiments. (B) Vero cells were co-transfected for 24 h
with pCMVβ and either: pRR1072, pRR1072Rep, PRKCDwt-UL34 Duo or PRKCDdn-UL34 Duo. Complementation of the vRR1072(tk+) was performed ﬁve times as previously
described (Bjerke et al., 2003). Error bars indicate standard deviations. p-values were determined via a paired Student t-test. (C) Digital images of western blots probed with
polyclonal antibody to PKC delta (top) and monoclonal antibody to actin (bottom). Equal amounts of total protein from total cell lysates from MCF-7 or BT-549 cells were probed.
(D) Replicate cultures of MCF-7 and BT-549 cells were infected at an MOI of 5 with HSV-1(F). At 24 hpi total culture virus was titrated on Vero cells. Virus yields are expressed as
plaque forming units (PFU) per milliliter. Each data point represents the mean of three experiments. Error bars indicate standard deviations.
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control (Supplemental Figure 3 B).
Our third approach was to evaluate HSV-1 replication in a cell line
with little or no endogenous PKC delta protein. It is possible that 70%
knockdown in HEp-2 cells was not sufﬁcient to reduce the level of PKC
delta total kinase activity to inhibit viral replication (Supplemental
Figure 3 A and B) or that the requirement for PKC delta during HSV-1
replication may be a cell type speciﬁc event. Using the NCI-60
microarray database, we identiﬁed a breast cancer epithelial cell line,
BT-549, with reduced mRNA expression levels of PRKCD. The NCI-60
data indicated that BT-549 cells express low levels of PRKCDmRNA as
compared to another breast cancer epithelial line, MCF-7, which have
a median expression proﬁle for PRKCD (http://dtp.nci.nih.gov/
mtweb/search.jsp). MCF-7 cells express readily detectable amounts
of PKC delta while BT-549 cells have almost undetectable levels of PKC
delta before or after infection (Fig. 4C and data not shown) (Jackson
et al., 2005). The breast cancer cells were infectedwith ﬁve PFU/cell of
WT HSV-1(F) and infectivity was determined at 24 hpi (Fig. 4D).
There was not a signiﬁcant difference in viral infectivity between
MCF-7 and BT-549 cells (Fig. 4D). Collectively, results from shRNA-
expressing and breast cancer cell comparisons suggest that protein
level of PKC delta does not signiﬁcantly alter WT HSV-1 replication
(Supplemental Figure 3 and Figure 4 D).
Emerin hyperphosphorylation is necessary for disassociation from the
lamina during HSV-1 infection
Another goal of this study was to determine if phosphorylation of
lamina components regulates their association with the nuclear
lamina during herpesvirus infection. It has been previously hypoth-
esized that recruitment of kinases to the NE and concurrent
phosphorylation of nuclear lamina proteins is one mechanism ofgenerating the necessary ﬂexibility in the lamina for primary
envelopment. However, it remains unknown if phosphorylation of
nuclear lamina proteins, such as emerin, is required for their re-
localization during HSV-1 infection. It also remains unknown if
phosphorylation of lamina components, LAPs and lamins, is required
for nuclear egress. Since HSV-1 induced emerin hyperphosphoryla-
tion is blocked in the absence of pUS3 kinase activity and in the
presence of Rottlerin (Leach et al., 2007), these conditions were used
as a tool to induce known phosphorylation states in emerin and to
determine whether hyperphosphorylation of emerin is required for
disassociation from the lamina.
HEp-2 cells were mock infected or infected with ﬁve PFU/cell of WT
or pUS3 kinase-dead virus (vRR1204) and treatment with vehicle
(DMSO) or Rottlerin began at ﬁve hpi. At 16 hpi, cells were ﬁxed and
stained for emerin and pUL34 and visualized by confocal microscopy
(Fig. 5A). Mock-infected HEp-2 cells exhibited smooth emerin localiza-
tion around the NE (Fig. 5A, a). WT-infected, vehicle-treated cells
demonstrated two changes in the appearance of emerin reactivity
(Leach et al., 2007). (i) Most emerin is still smoothly distributed in the
nuclear membrane and reveals the infection-dependent alteration of
the contourof theNE froma smoothovoid to awrinkledovoid. (ii) Some
emerin is localized to blebs that appear both inside and outside the NE.
In both places it co-localizes with pUL34 (Fig. 5A d, e, f). One of the two
changes in emerin appearance is lost in WT virus-infected, Rottlerin-
treated cells. All emerin is smoothly distributed in the nuclear
membrane and the interior and exterior membrane but the blebs are
absent (Fig. 5A compareg tod). The contourof theNE is still altered to an
irregular ovoid in the presence of Rottlerin (Fig. 5A h, i), suggesting that
the NE contour change is not dependent on Rottlerin-sensitive
phosphorylation events.
It has been previously demonstrated that in the absence of pUS3
activity and in the presence of Rottlerin treatment, emerinmodiﬁcation
132 N.R. Leach, R.J. Roller / Virology 406 (2010) 127–137is indistinguishable from that in uninfected cells (Leach et al., 2007).
Based on the results from Fig. 5A a–i, our hypothesis would predict that
under these same conditions (pUS3-kinase dead and presence of
Rottlerin), emerin localization would resemble that seen in mock-infected cells. pUS3 kinase-dead (vRR1204)-infected, vehicle-treated
cells showed pUL34 and emerin co-localization in puncta around theNE
indicating dissociation from the nuclear lamina (Leach et al., 2007)
(Fig. 5A j, k, l). As predicted, pUS3 kinase-dead (vRR1204)-infected,
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frommock (Fig. 5A compare m to a). Interestingly, although pUL34 and
emerin are binding partners, pUL34 still localized in puncta (Fig. 5A, n)
and no longer co-localized with emerin (Fig. 5A, o) (Leach et al., 2007).
These results suggest that emerinhyperphosphorylation is necessary for
its disassociation from the lamina and for its association with pUL34.
We previously reported pUL34-dependent, pUS3-independent
emerin phosphorylation events are sensitive to Rottlerin treatment.
These data suggested that pUL34-dependent, phosphorylation is
mediated by the cellular kinase PKC delta (Leach et al., 2007).
However, the usefulness of Rottlerin as a PKC delta inhibitor has since
been brought into question. Additionally, data presented in Figs. 1, 2,
and 4 suggest that while inhibition of the entire PKC family leads to a
nuclear egress block, PKC delta nor cPKCs are not uniquely required
for HSV replication. To test if the pUL34-dependent emerin
phosphorylation event relies on the activity of a PKC isoform, HEp2
cells weremock infected or infectedwith ﬁve PFU/cell ofWT or pUS3
kinase-dead (vRR1204) viruses. At ﬁve hpi, treatment began with
vehicle (DMSO) (D), Rottlerin (R), or BIM I (B). At 16 hpi, lamina
preparations were performed, proteins were separated on an SDS-
PAGE gel, transferred to nitrocellulose, and then probed for emerin
(Fig. 5B). As shown previously, infection with WT HSV-1 induces
hyperphosphorylation of emerin, resulting in the appearance of
multiple bands that migrate more slowly than the single major band
seen in uninfected cells (compare lanes one and two) (Leach et al.,
2007). Emerin hyperphosphorylation is reduced in the absence of
pUS3 kinase activity (lane ﬁve, two bands) or in the presence of
Rottlerin (lane four, middle band is most prominent), and is
completely eliminated in cells infected with vRR1204 and treated
with Rottlerin (compare lanes seven (one species) and eight).
Treatment with BIM I, however, does not result in any change in
hyper-phosphorylated species present in cells infected with either
WT (compare lanes two and three) or pUS3 kinase-dead virus
(compare lanes ﬁve and six, two species in each lane). Similar results
were observed in Vero cells (data not shown). The lack of mobility
shift upon BIM I treatment suggests that BIM I inhibition of PKC
isoforms late in HSV-1 infection does not affect HSV-1 induced
emerin hyperphosphorylation.
Emerin localization in the infected cell nuclear membrane depends
upon its phosphorylation state yet BIM I treatment does not alter
emerin's phosphorylation state (Fig. 5A and B). Therefore, we would
predict BIM I treatment would not alter emerin localization. To test this
prediction, the same experimental conditions were used as in Fig. 5A
except PKCs were inhibited by treatment with vehicle (DMSO) or BIM I
beginning atﬁve hpi. At 20hpi, the cellswereﬁxed in formaldehyde and
prepared for confocal microscopy (Fig. 5C). Consistent with our
hypothesis, emerin mislocalization and co-localization with pUL34
were not appreciably changed by treatment with BIM I in cells infected
with either WT virus (Fig. 5C, compare panels d–f and g–i) or pUS3
kinase-dead virus (Fig. 5C compare panels j–l and m–o).
PKC delta is recruited to the nuclear envelope during HSV-1
infection (Supplemental Figure 2 Bd) (Park and Baines, 2006). Emerin
appears to be re-localized in a phosphorylation dependent manner
(Fig. 5A), however, inhibition of the entire PKC family did not block
emerin hyperphosphorylation (Fig. 5B). To test for a speciﬁc role forFig. 5.Disruption of emerin localization in HSV-1-infected HEp-2 cells is sensitive to pUS3-me
PKC delta activity. (A) Shown are digital confocal images of optical sections taken near the m
(F) (d–i) or pUS3 kinase-dead (vRR1204) (j–o) with ﬁve PFU/cell for 20 h and treated with
with antibodies directed against emerin (left column) or pUL34 (center column). Emerin is
HEp-2 cell nuclear lamina preparations. Cells were mock infected or infected with ﬁve PFU
treatment with vehicle (D), BIM I (B), or Rottlerin (R) and were harvested for lamina prepara
the dots in lanes ﬁve, six, and seven indicate double or single emerin species. (C) Shown are
cells that were uninfected (a–c), HSV-1(F) (d–i), or pUS3 kinase-dead (vRR1204) (j–o) infec
m–o) beginning at ﬁve hpi. Cells were stained with antibodies directed against emerin (left
(D) Digital confocal images taken near the center of nuclei of EGFP-Emerin HEp-2 B2 cells.
PRKCDdn-UL34 Duo (g, h, i) for 24 h. Cells were then infected with pUS3 kinase-dead (vRR
antibodies directed against FLAG-PKC delta (middle column) or pUL34 (right column). EmePKC delta activity in HSV-1-induced emerin re-localization, cells from
a stable EGFP-emerin-expressing HEp-2 cell line were transfected
with PRKCDwt-UL34 Duo or PRKCDdn-UL34 Duo. One day later, the
cells were infected with 20 PFU/cell pUS3 kinase-dead virus. At 20
hpi, cells were ﬁxed and processed for detection of FLAG and pUL34 by
immunoﬂuorescence (Fig. 5D). If PKC delta activity is required for
emerin re-localization in the absence of pUS3 activity, then PRKCDdn-
UL34 Duo transfected cells should be unable to localize emerin to
puncta. Contrary to our hypothesis, emerin re-localization to puncta
was observed in cells that express both PRKCDwt and PRKCDdn
(Fig. 5D, compare panels d–f and g–i).
Discussion
The involvement of PKCs in nuclear egress of herpesviruses
appears to be a conserved property of herpesviruses. Both PKC
alpha and delta, but not zeta, are recruited to the NE in HSV-1
infection while cPKCs are recruited upon HCMV infection (Muranyi
et al., 2002; Park and Baines, 2006). For HSV, HCMV and MCMV, PKC
recruitment depends on expression of pUL34 (or its HCMV andMCMV
homologs pUL50 andM50), further suggesting a role in nuclear egress
of capsids (Muranyi et al., 2002; Park and Baines, 2006). In the case of
HCMV, recruitment of cPKCs to the NE also requires cPKC activity,
since recruitment can be inhibited by the speciﬁc cPKC inhibitor Ro-
31-7549 (Muranyi et al., 2002). Data presented here support the
hypothesis that the PKC activity is required for replication of HSV and
speciﬁcally, for nuclear egress of the virus capsid. Inhibition of all PKC
isoforms by the pan-PKC inhibitor BIM I beginning at 5 h post-
infection, results in a ﬁve-fold reduction in new virus production
(Fig. 1). The reduction in new virus production is accompanied by
retention of capsids in the cell nucleus (Table 1) suggesting that it is at
least partially attributable to inhibition of nuclear egress. This is the
ﬁrst evidence that PKC function is required for efﬁcient nuclear egress
and supports the hypothesis that phosphorylation-mediated nuclear
lamina breakdown is important for herpesvirus nuclear egress.
Interestingly, our data also suggest a role for PKC function in
formation or stability of capsids (Table 1). BIM I inhibition of PKC
activity reduced the overall number of capsids in infected cells
(DMSO-631 vs. BIM I-223). The reduction in capsid number is not
apparently due to overall diminished viral protein synthesis late in
infection since we observed no inhibition of overall protein synthesis
(Fig. 3). The decrease in capsid number could be attributable an
important function of PKCs in capsid assembly or stability, directly or
indirectly through signaling events. These data suggest that of PKC
activity is involved in (i) accumulation of capsids and (ii) egress of
capsids that do accumulate from the nucleus.
The recruitment of conventional PKCs to the NE during HSV and
CMV infection suggests speciﬁc roles for cPKCs in herpesvirus nuclear
egress (Muranyi et al., 2002; Park and Baines, 2006). We tested for a
unique role for cPKCs in HSV infection by use of a speciﬁc chemical
inhibitor, and were surprised to observe that inhibition of cPKCs with
Ro-31-7549 had no effect on replication (Fig. 4A). This suggests that
cPKCs do not have a unique, speciﬁc role in HSV replication.
Recruitment of PKC delta to the NE in a pUL34-dependent manner
in HSV-infected cells suggested that PKC delta might be required fordiated and Rottlerin sensitive kinase phosphorylation events but not BIM I treatment or
iddle of the nuclei of HEp-2 cells that were uninfected (a–c) or infected with WT HSV-1
vehicle (a–f and j–l) or Rottlerin (g–i and m–o) beginning at ﬁve hpi. Cells were stained
represented in red and pUL34 in green. (B) Digital image of western blot for emerin in
/cell of either WT or pUS3 kinase-dead (vRR1204) HSV-1(F). At ﬁve hpi, cells began
tions at 16 hpi. The arrow in lane four indicates the predominant middle species, while
digital confocal images of optical sections taken near the middle of the nuclei of HEp-2
ted with ﬁve PFU/cell for 20 h and treated with vehicle (a–f and j–k) or BIM I (g–i, and
column) or pUL34 (center column). Emerin is represented in green and pUL34 in red.
Cells were un-transfected (a, b, c) or transfected with PRKCDwt-UL34 Duo (d, e, f) or
1204) at an MOI of 20 for 20 h. Cells were ﬁxed with formaldehyde and stained with
rin is represented in green, PKC delta in blue, and pUL34 in red.
Fig. 6. Model of HSV-1 induced nuclear lamina disruption. (1) In the un-infected cell,
emerin is bound to the lamins via interactionwith lamin A/C. Emerin is intended to be a
prototype LAP protein and may behave in the cell similarly to MAN1 or other LAPs.
(2) Upon infection with HSV-1, pUL34 and pUL31 are expressed and accumulated as a
complex at the inner nuclear membrane (INM). pUL34/pUL31 recruits pUS3, the alpha-
herpesvirus viral kinase, PKCs, and Rottlerin Sensitive Kinases (RttSK) to the NE to
phosphorylate emerin, lamins and pUL34/pUL31. Arrows indicate that pUS3 and RttSK
are known to be necessary for phosphorylation of emerin, pUL34/pUL31, and lamin B.
(3) Phosphorylation of lamins and emerin, prevents there binding and creates
ﬂexibility within the lamina necessary for nuclear egress. PKCs, RttSK, and pUS3 are
depicted near the INM due to their localization at the NE during infection.
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prior to nuclear egress (Park and Baines, 2006). Similar to cPKCs,
inhibition of PKC delta had no effect on viral replication (Fig. 4B and
Supplemental Figure 3). These results for cPKCs and PKC delta, along
with our ﬁndings that inhibition of the entire family (Fig. 1) does
inhibit HSV-1 replication are consistent with two hypotheses. First, it
is possible that the functions of cPKCs and PKC delta are redundant.
Second, it is also possible that these kinases are in fact irrelevant and
that some other PKC isoform (perhaps another of the nPKCs or aPKC)
plays an important role in viral replication and nuclear egress.
Emerin and lamin B have both been reported to be phosphorylated
by PKC delta in HSV-1-infected cells (Leach et al., 2007; Park and
Baines, 2006). However, this conclusion was based on sensitivity of
phosphorylation to Rottlerin. Since it has become clear that Rottlerin
is not a speciﬁc PKC delta inhibitor in intact cells, we re-examined the
dependence of emerin hyperphosphorylation on PKC activity. HSV-1-
induced emerin hyperphosphorylation does not appear to be
dependent on activity of a PKC isoform since its mobility in SDS-
PAGE was not altered by the inhibition of all PKC isoforms with BIM I
(Fig. 5B), and its infected cell localization was not altered by
expression of DN-PKC delta (Fig. 5D). This creates a class of enzymes
we termed Rottlerin sensitive kinases (RttSK) since they are sensitive
to Rottlerin but not speciﬁc PKC delta inhibition. The RttSK
responsible for pUL34-dependent emerin phosphorylation remains
unknown at this time, but possible candidates include: AKT, PDK1,
JNK1alpha, GSK3beta, PKA, and/or MSK1 (Soltoff, 2007).
Our data also show that protein synthesis in uninfected HEp-2 and
Vero cells is dependent on PKC activity, but protein synthesis in wild-
type HSV-infected cells is not (Fig. 3). Therefore, HSV infection
apparently protects the infected cell protein synthesis machinery
from the effect of PKC inhibition. PKC isoforms have been identiﬁed
mostly as positive regulators of translation in different cell types and
in response to different stimuli. Positive effects on translation have
mostly been attributed to indirect signaling effects through Erk, MAPK
or mTOR signaling pathways (Aeder et al., 2004; Akimoto et al., 1998;
Herbert et al., 2000; Kumar et al., 2000; Romanelli et al., 1999; Wang
et al., 2003), but cPKCs have also been reported to directly
phosphorylate eIF4e (Whalen et al., 1996). The difference between
infected and uninfected cells in PKC dependence of protein synthesis
suggests that HSV infection provides a functional substitute for PKC in
maintenance of protein synthesis. HSV-1 is known to protect host
protein synthesis from protein kinase R (PKR)-induced shut-off
through pUS11 and ICP34.5 (Mohr, 2006). It may be that the virus
encodes or induces other activities to maintain robust synthesis of
viral proteins.
Many lines of evidence suggest that localization and function of
emerin is regulated by its phosphorylation state. Studies in a Xenopus
oocyte cell-free system demonstrated that emerin binding to barrier
to auto-integration factor (BAF) was un-coupled by a mitotic
phosphorylation event on Ser 175 (Hirano et al., 2005). Emerin is
phosphorylated in a cell cycle-dependent manner, with maximal
phosphorylation observed during mitosis (Ellis et al., 1998). Some
Emery–Dreifuss Muscular Dystrophy (EDMD) patients with mutant
emerin have increased emerin phosphorylation that correlates with
emerin mislocalization away from the NE suggesting that phosphor-
ylation regulates emerin localization and function and aberrant
phosphorylation may contribute to EDMD pathogenesis (Ellis et al.,
1998; Manilal et al., 1998; Somech et al., 2005). Emerin is hyperpho-
sphorylated in HSV-1 infected cells, and this is correlated with
disconnection of emerin from lamin A/C (Leach et al., 2007). From
these data we hypothesized that emerin disassociation from the
lamina is caused by its phosphorylation state (Fig. 5A). Using
conditions shown previously to completely ablate emerin hyperpho-
sphorylation, we observed that, in fact, these same conditions result in
maintenance of emerin connections to the lamina but not to pUL34
(Fig. 5A). Although PKC activity appears important for HSV-1 growthdue to a block in (i) nuclear egress and (ii) capsid accumulation, it
does not appear to be involved in the hyperphosphorylation of emerin
(Fig. 5B). This was surprising since emerin hyperphosphorylation is
sensitive to Rottlerin treatment (Fig. 5B) (Leach et al., 2007). Emerin
localization also is insensitive to PKC delta activity (Fig. 5D), although
this enzyme is recruited to the NE (Supplemental Figure 2 B) (Park
and Baines, 2006). It remains unknown which cellular enzyme
mediates emerin hyperphosphorylation, and if phosphorylation of
emerin is required for nuclear egress.
All of these data are consistent with the following model (Fig. 6).
(1) Emerin is bound to lamin A/C in the uninfected cell. It is also
anchored to the INM via its transmembrane domain. (2) Upon HSV-1
infection, pUL34 and pUL31 are expressed and assemble a complex.
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domain. The pUL34/pUL31 complex recruits PKC isoforms, pUS3, and
non-PKC Rottlerin sensitive kinase(s) to the NE. Emerin, lamin A,
lamin C, and lamin B are phosphorylated. Independently of pUL34/
pUL31, pUS3 can be recruited to phosphorylate emerin (3).
Phosphorylated emerin no longer interacts with phosphorylated
lamin A/C creating the ﬂexibility necessary for the capsid to bypass
the lamina and access INM for envelopment. In this model, emerin is
the prototype LAP and it remains to be determined if the localization
and interactions of other LAPs, such as MAN1 or LBR, are regulated by
phosphorylation in the infected cell as emerin appears to be.
Materials and methods
Cells, viruses, and chemicals
HEp-2 and Vero cells were maintained as previously described
(Roller et al., 2000). MCF-7 and BT-549 cells were maintained in RPMI
containing 10% fetal calf serum. BT-549 cells were derived from the
NCI-60 cell collection and were kindly provided by Jack Stapleton. The
properties of HSV-1(F), vRR1072(tk+) (UL34-null mutant virus),
vRR1202 (US3-null virus), vRR1204 (US3 kinase-dead virus K220A),
and repair viruses for vRR1072(tk+) (vRR1072Rep) and vRR1202
(vRR1202Rep) were previously described and characterized (Rey-
eynolds et al., 2001; Roller et al., 2000; Ryckman and Roller, 2004).
Rottlerin (Santa Cruz Biotechnology) was diluted in DMSO to a stock
concentration of 10 mM and used to treat cells at 10 μM. Ro-31-7539
(Calbiochem) was diluted in DMSO to a stock concentration of 1 mM
and used to treat cells at 1 μM while bisindolylmaleimide I (BIM I- LC
Laboratories) was diluted in DMSO to a stock concentration of 500 μM
and used at 10 μM. For IFNβ (Interferon β) treatment, HEp-2 cells
were serum starved in DMEM without serum overnight, and then
exposed to 1000 U of Human recombinant IFNβ (IBL) for 30 min.
Phorbol 12-myristate 13-acetate (PMA) was kindly provided by
Jeffery Meier (Sigma). PMA was used at 20 nM to activate PKCs for
30 min.
Plasmids and cell lines
pRR1072Rep, which expresses wild-type HSV-1 UL34 from its own
promoter, has been previously described (Roller et al., 2000). The FLAG
epitope-tagged rat wild-type and K376M (dominant negative) PKC
delta expressionvectorswere kindly providedbyU.Kikkawa (Konishi et
al., 1997). pRR1342 (PRKCDwt-UL34 Duo) and pRR1343 (PRKCDdn-
UL34 Duo), which express either wild-type or K376M FLAG epitope
tagged rat PKC delta (respectively) and wild-type HSV-1 UL34 were
constructed by ligation of the 3.05 kb XbaI–NgoMIV fragment of
pRR1072Rep and the 5.44 kb fragment of the corresponding PKC delta
expression vectors. In pRR1342 andpRR1343, PKCdelta is constitutively
expressed from the human cytomegalovirus major immediate early
promoter (HCMV MIEP), and pUL34 is expressed in a HSV infection-
dependentmanner from its own promoter. The HuSH shRNA constructs
against PKC delta (product number TR320468) were purchased from
OriGene. In order to construct stable clonal cells lines expressing HuSH
shRNAs against PKC delta, HEp-2 cells were transfected with individual
HuSH shRNA constructs and then selected with 0.5 μg/mL puromycin
for 1 week. Colonies were then scraped from the plate, transferred to
individual cultures, and ampliﬁed. The HuSH cell lines shRNA-control,
shRNA-PRKCD-1, shRNA-PRKCD-2, and shPRKCD-PRKCD-3 constitu-
tively express the following HuSH plasmids respectively: TR30003,
TI379089, TI379090, and TI379090. To create the Strep-His-EGFP-
emerin plasmid, PCR ampliﬁcation of EGFP from the EGFP-emerin-C1
plasmid from Y. Hiraoka (Leach et al., 2007) was performed with the
following primers: 5' CACAGCTAGCCATGGCGTGGAGCCACCCCCAGTTC-
GAAAAGGCGCACCATCACCATCACCATCACCATATGGTGAGCAAGGGC-
GAGGA 3' and 5' AGTTGTCCATGGATCTGAGTCCGGA 3'. The 0.8 kb PCRproduct and EGPF-emerin-C1 were digested with Nhe1 and BspE1 and
thePCRproductwas ligated into the 4.6 kbproduct of the EGFP-emerin-
C1 digestion to create pRR1315. To create the retroviral expression
plasmid for Strep-His-EGFP-emerin, Strep-His-EGFP-emerin was PCR
ampliﬁed from pRR1315 using the following primers: 5'-CACAGT-
TAACGCTAGCCATGGCGTGGAGC-3' and 5'-CACAGCTCGAGATCCTA-
GAAGGGGTTGC-3'. This 1.6 kb PCR product and 5.9 kb pLXSN vector
were digested with Xho1 and Hpa1 and ligated to create pRR1319.
pLXSN was kindly provided by A. Klingelhutz. The University of Iowa
Vector Core used pRR1319 to generate aMoMLVpseudotyped retroviral
transduction particle. These particles were used to transduce HEp-2
cells. 48 h post transduction, cellswere placed under G-418 selection for
2 weeks. Colonies were then scraped from the plate, transferred to
individual cultures, and ampliﬁed to create the HEp-2 Strep-His-EFGP-
emerin B2 cell line.
Indirect immunoﬂuorescence
Indirect immunoﬂuorescence (IF)wasperformed for pUL34, emerin,
lamin A/C and FLAG-epitope-tagged PKC delta as previously described
(Bjerke andRoller, 2006b; Reynolds et al., 2001). Brieﬂy, cellswereﬁxed
with 4% formaldehyde for 10 min, washed with phosphate-buffered
saline (PBS), and then permeabilized and blocked in the same stepwith
IF buffer (0.5% Triton X-100, 0.5% Sodium Deoxycholate, 1% BSA, 0.05%
SodiumAzide diluted in PBS) for 1 h. Primary antibodieswere diluted in
IF buffer as follows: chicken anti-UL34, 1:1000 (Reynolds et al., 2001);
mouse monoclonal anti-lamin A/C, 1:1000 (Santa Cruz Biotechnology,
sc-7292); mouse monoclonal anti-emerin, 1:500 (Santa Cruz Biotech-
nology, sc-25284); mouse monoclonal anti-FLAG M2, 1:1000 (Sigma,
F1804). The procedure for STAT3-pTyr705 localization differed in that
cells were ﬁxed in coldmethanol for 30 min, dried, and rehydrated in IF
buffer. Rabbit polyclonal anti-STAT3-pTyr705 (Cell Signaling, #1938),
was diluted 1:400.
Secondary antibodies were diluted 1:1000 in IF buffer as follows:
Alexa Fluor goat anti-chicken IgG (Invitrogen, A11001), Alexa Fluor
goat anti-mouse IgG (Invitrogen, A1104), Alexa Flour donkey anti-
rabbit IgG (Invitrogen, A21206). Slo-fade II (Invitrogen, Molecular
Probes) was used to mount cover slips on glass slides. All confocal
microscopy work was done with a Zeiss 510 microscope except
Fig. 5D and Supplemental Figure 2, whichwere performed on a BioRad
Multiphoton microscope.
SDS-PAGE sample preparations
For analysis of viral protein expression and PKC delta protein
expression, infected or uninfected cultures containing 2×106 cells were
washed twice with PBS, scraped into PBS, pelleted at low speed, total
soluble protein was extracted with acetic acid, and precipitated with
acetone as previously described (Roller et al., 1996). Total protein
concentration was determined using BioRad Dc Protein Assay (BioRad
Laboratories). MEK 1/2 lysates were prepared differently in that after
collecting the treated cultures containing 2×106 cells after with a low
speed spin, total soluble protein was extracted with SDS-PAGE sample
buffer and PBS. This total cell lysate was denatured at 70 °C, sonicated
twice for 30 s each, and then total protein concentration was
determined with BioRad Dc Protein Assay (BioRad Laboratories).
Preparation of nuclear fractions
Nuclear-lamina fractions were prepared as described in (Leach
et al., 2007).
Western blot
The antibodies and dilutions used were: mouse monoclonal anti-
emerin, 1:500 (Santa Cruz, sc-25284); rabbit polyclonal anti-PKC
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1:1000 (Roller and Roizman, 1992); chicken monoclonal anti-UL34,
1:1000 (Reynolds et al., 2001); mouse monoclonal anti-VP5, 1:1000
(Meridian Life Science, #C05014M); mouse anti-actin, 1:1000 (Sigma,
A3853); mouse monoclonal anti-gC, 1:1000 (Virusys, H1A022M);
rabbit monoclonal anti-phos-MEK 1/2 Ser 217/221, 1:1000 (Cell
Signaling, 9154); rabbit monoclonal anti-MEK 1/2 (Cell Signaling,
9122). Alkaline phosphatase conjugated anti-mouse, anti-rabbit, and
anti-chicken secondary antibodies were incubated with the appro-
priate blot for 30 min (Sigma, mouse: A3562, rabbit: A3687 Aves Lab,
chicken: AP1001).
Virus growth
Single-step growth analysis was performed as previously de-
scribed (Reynolds et al., 2002; Roller et al., 2000). Brieﬂy, replicate
cultures of cells were infected at anMOI of ﬁve, and residual virus was
removed or inactivated with a low-pH-buffer wash. Cells were
untreated or treated with DMSO, Ro-31-7549 (1 μM), or BIM I
(10 μM) at ﬁve hpi. At 24 hpi, virus was harvested and total culture
PFU were calculated by titration on Vero cells.
Transmission electron microscopy
Vero cells were infected with HSV-1(F) at anMOI of ﬁve and at ﬁve
hpi cells were treated with DMSO or BIM I. At 16 hpi, cells were ﬁxed
with glutaraldehyde, processed, and analyzed by electron microscopy
as described previously (Roller et al., 2000).
35-S-methionine labeling
2×106 HEp-2 cells were uninfected or infected with ﬁve PFU/cell
of HSV-1(F) and beginning at ﬁve hpi, the cells were treated with
DMSO (D) or BIM I (B). At 9 hpi, the cells were starved for methionine
by replacing the media with methionine minus media (Gibco, 21013)
with DMSO or BIM I. Beginning at 14 hpi, each sample was labeled for
2 h with 20 μCi of 35 S-methionine. Total cell lysates were prepared at
16 hpi by the acid preparation as described above (Roller et al., 1996).
Total protein from equal numbers of cells was separated on an SDS-
PAGE gel and visualized by autoradiography.
Complementation assays
Twelve-well cultures of Vero cells containing 4×105 cells were
transfected with a total of 650 ng of plasmid DNA using 5 μl of
LipofectAmine Reagent according to the manufacturer's instructions.
Complementation assays were performed on the transfected cultures
as previously described (Bjerke et al., 2003).
Inhibitor toxicity assays
2×105 HEp-2 and Vero cells were plated in a 48 well dish in
triplicate. 12 h later, cells were treated with vehicle (DMSO), 10 μM
Rottlerin, 10 μMBIM I, and 1 μMRo-31-3549. 24 h post-treatment, the
ATPLite assay (Perkin-Elmer, #6016739) was followed per manufac-
turer's directions. This was repeated three independent times to
determine that at the indicated dosage, the kinase inhibitors did not
induce signiﬁcant toxicity compared to vehicle (DMSO).
Inhibitor signaling assays
2×106 HEp-2 cells were placed into the presence of 10 μM BIM I,
1 μMRo-31-7549 or vehicle for 2 h, followed by a 30-min activation of
PKCs with 20 nM PMA. The cells were washed twice with PBS, then
pelleted at low speed, resuspended in PBS and SDS-PAGE buffer.
Protein concentration was determined using the BioRad Dc Assaydescribed above. These lysates were subjected to western blot
analysis for MEK 1/2 and phos-MEK 1/2.
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